These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24602846)
1. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer. Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846 [TBL] [Abstract][Full Text] [Related]
2. [GRP78 expression in gastric cancer and its clinical significance]. Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482 [TBL] [Abstract][Full Text] [Related]
3. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer. Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822 [TBL] [Abstract][Full Text] [Related]
4. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Daneshmand S; Quek ML; Lin E; Lee C; Cote RJ; Hawes D; Cai J; Groshen S; Lieskovsky G; Skinner DG; Lee AS; Pinski J Hum Pathol; 2007 Oct; 38(10):1547-52. PubMed ID: 17640713 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma. Ogawa H; Kaira K; Takahashi K; Shimizu A; Altan B; Yoshinari D; Asao T; Oyama T Cancer Biomark; 2017 Sep; 20(3):273-281. PubMed ID: 28854502 [TBL] [Abstract][Full Text] [Related]
6. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Lee E; Nichols P; Spicer D; Groshen S; Yu MC; Lee AS Cancer Res; 2006 Aug; 66(16):7849-53. PubMed ID: 16912156 [TBL] [Abstract][Full Text] [Related]
7. GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Lee E; Nichols P; Groshen S; Spicer D; Lee AS Int J Cancer; 2011 Feb; 128(3):726-31. PubMed ID: 20473863 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy. Zhou J; Qian S; Li H; He W; Tan X; Zhang Q; Han G; Chen G; Luo R Tumour Biol; 2015 May; 36(5):3941-7. PubMed ID: 25773385 [TBL] [Abstract][Full Text] [Related]
10. miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111 [TBL] [Abstract][Full Text] [Related]
11. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473 [TBL] [Abstract][Full Text] [Related]
12. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Zhang J; Jiang Y; Jia Z; Li Q; Gong W; Wang L; Wei D; Yao J; Fang S; Xie K Clin Exp Metastasis; 2006; 23(7-8):401-10. PubMed ID: 17187227 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TMPRSS4 in gastric cancer. Sheng H; Shen W; Zeng J; Xi L; Deng L Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317 [TBL] [Abstract][Full Text] [Related]
14. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer. Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of PAK4 expression in gastric cancer. Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788 [TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
18. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses. Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197 [TBL] [Abstract][Full Text] [Related]
19. Expression of glucose regulated protein 78 (GRP78) determines colorectal cancer response to chemotherapy. Mhaidat NM; Alzoubi KH; Almomani N; Khabour OF Cancer Biomark; 2015; 15(2):197-203. PubMed ID: 25519021 [TBL] [Abstract][Full Text] [Related]
20. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer. Cheng Y; Yang B; Xi Y; Chen X Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]